Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Open-market sale PRESIDENT AND CEO sold 6,954 shares at $9.06 ($63,003)
  2. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $14.20 ($16,813)
  3. 4 Planned sale PRESIDENT AND CEO sold 20,000 shares at $14.60 ($292,000)
  4. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $13.13 ($15,546)
  5. 4 Planned sale PRESIDENT AND CEO sold 10,000 shares at $12.77 ($127,700)
  6. 4 Planned sale Chief Commercial Officer sold 1,184 shares at $12.75 ($15,096)
  7. 4 Planned sale President and CEO sold 10,000 shares at $12.42 ($124,200)
  8. 4 Open-market sale Chief Commercial Officer sold 2,868 shares at $10.34 ($29,655)
  9. 4 Open-market sale Interim CFO sold 942 shares at an average $10.34 ($9,739)
  10. 4 Open-market sale General Counsel sold 3,809 shares at an average $10.34 ($39,381)
  11. 4 Open-market sale President and CEO sold 6,676 shares at $10.34 ($69,030)
  12. 4 Planned sale Chief Commercial Officer sold 1,184 shares at $10.60 ($12,550)
  13. 4 Planned sale Chief Commercial Officer sold 1,184 shares at $8.35 ($9,886)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Chief Commercial Officer sold 1,184 shares at $10.51 ($12,444)
  16. 4 Open-market sale Chief Financial Officer sold 4,219 shares at an average $10.00 ($42,201)
  17. 4 Open-market sale Chief Commercial Officer sold 2,843 shares at $10.01 ($28,458)
  18. 4 Open-market sale General Counsel sold 3,772 shares at $10.01 ($37,758)
  19. 4 Open-market sale President and CEO sold 6,527 shares at $10.01 ($65,335)
  20. 4 Planned sale Chief Commercial Officer sold 1,184 shares at $10.54 ($12,479)

Page 5 of 12 · 229 filings